If you made any changes in Pure these will be visible here soon.

Research Output 1990 2019

Analysis of serum interleukin(IL)-1α, IL-1β and IL-18 in patients with systemic sclerosis

Lin, E., Vincent, F. B., Sahhar, J., Ngian, G-S., Kandane-Rathnayake, R., Mende, R., Morand, E. F., Lang, T. & Harris, J., 1 Jan 2019, In : Clinical and Translational Immunology. 8, 4, 11 p., e1045.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Attainment of the lupus low disease activity state is associated with protection from damage accrual in patients with active disease at baseline

Golder, V., Morand, E. F., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Wu, Y-J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O’Neill, S., Goldblatt, F., Sing Lau, C., Li, Z. & 2 others, Hoi, A. & Nikpour, M., 2019, p. 203-203. 1 p.

Research output: Contribution to conferenceAbstractOtherpeer-review

Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A. & Nikpour, M., 2019. 1 p.

Research output: Contribution to conferenceAbstractOtherpeer-review

Could GILZ be the answer to glucocorticoid toxicity in lupus?

Flynn, J. K., Dankers, W. & Morand, E. F., 17 Jul 2019, In : Frontiers in Immunology. 10, JULY, 13 p., 1684.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File

Development of the Asia Pacific Lupus Collaboration cohort

Kandane-Rathnayake, R., Golder, V., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Li, Z., An, Y., Lateef, A., Sockalingam, S., Navarra, S. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O’Neill, S., Goldblatt, F., Hao, Y., Zhang, Z., Al-Saleh, J. & 8 others, Khamashta, M., Takeuchi, T., Tanaka, Y., Bae, S. C., Sing Lau, C., Hoi, A., Nikpour, M. & Morand, E. F., 1 Mar 2019, In : International Journal of Rheumatic Diseases. 22, 3, p. 425-433 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Effect of storage duration on cytokine stability in human serum and plasma

Vincent, F. B., Nim, H. T., Lee, J. P. W., Morand, E. F. & Harris, J., Jan 2019, In : Cytokine. 113, p. 453-457 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

Golder, V., Kandane-Rathnayake, R., Huq, M., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O'Neill, S., Goldblatt, F., Lau, C. S., Li, Z. G., Hoi, A., Nikpour, M. & 2 others, Morand, E. F. & for the Asia Pacific Lupus Collaboration, Oct 2019, In : The Lancet Rheumatology. 1, 2, p. e103-e110 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Global consensus building and prioritisation of fundamental lupus challenges: The ALPHA project

Manzi, S., Raymond, S., Tse, K., Peña, Y., Anderson, A., Arntsen, K., Bae, S. C., Bruce, I., Dörner, T., Getz, K., Hanrahan, L., Kao, A., Morand, E., Rovin, B., Schanberg, L. E., Von Feldt, J. M., Werth, V. P. & Costenbader, K., 1 Jul 2019, In : Lupus Science and Medicine. 6, 1, 7 p., e000342.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus

Oon, S., Huq, M., Golder, V., Ong, P. X., Morand, E. F. & Nikpour, M., 1 May 2019, In : Annals of the Rheumatic Diseases. 78, 5, p. 29-633 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H. T., Louthrenoo, W., Luo, S. F., Jan Wu, Y. J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O'Neill, S., Goldblatt, F., Sing Lau, C., Li, Z. G., Hoi, A. & 2 others, Nikpour, M. & Morand, E. F., Oct 2019, In : The Lancet Rheumatology. 1, 2, p. e95-e102 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Lupus Low Disease Activity State is Associated with Reduced Direct Healthcare Costs in Patients with Systemic Lupus Erythematosus

Yeo, A. L., Koelmeyer, R., Kandane-Rathnayake, R., Golder, V., Hoi, A., Huq, M., Hammond, E., Nab, H., Nikpour, M. & Morand, E. F., 8 Jul 2019, (Accepted/In press) In : Arthritis Care and Research. 19 p.

Research output: Contribution to journalArticleResearchpeer-review

Outcomes of patients admitted to hospital medical units with back pain

Kyi, L., Kandane-Rathnayake, R., Morand, E. & Roberts, L., 1 Mar 2019, In : Internal Medicine Journal. 49, 3, p. 316-322 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Prospective multicenter validation of the lupus low disease activity state (LLDAS) treatment target

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A. & Nikpour, M., 2019, p. 25. 1 p.

Research output: Contribution to conferenceAbstractOtherpeer-review

Rediscovering MIF: New Tricks for an Old Cytokine

Harris, J., VanPatten, S., Deen, N. S., Al-Abed, Y. & Morand, E. F., 1 May 2019, In : Trends in Immunology. 40, 5, p. 447-462 16 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjögren's syndrome

Vincent, F. B., Lang, T., Kandane-Rathnayake, R. K., Downie-Doyle, S., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Joint Bone Spine. 86, 3, p. 393-395 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Clinical and Experimental Rheumatology. 37, 3, p. 254-256 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren’s syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay-Fisson, F., Morand, E. F. & Rischmueller, M., 2019, (Accepted/In press) In : Clinical and Experimental Rheumatology. 3 p.

Research output: Contribution to journalLetterResearchpeer-review

Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity

Yang, H., Xia, L., Chen, J., Zhang, S., Martin, V., Li, Q., Lin, S., Chen, J., Calmette, J., Lu, M., Fu, L., Yang, J., Pan, Z., Yu, K., He, J., Morand, E., Schlecht-Louf, G., Krzysiek, R., Zitvogel, L., Kang, B. & 7 others, Zhang, Z., Leader, A., Zhou, P., Lanfumey, L., Shi, M., Kroemer, G. & Ma, Y., 1 Sep 2019, In : Nature Medicine. 25, 9, p. 1428-1441 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Therapeutic trajectories following high disease activity state in SLE

McMaster, C., Nim, H., Koelmeyer, R., Frauman, A., Morand, E. & Hoi, A. Y., 2019. 1 p.

Research output: Contribution to conferenceAbstractOtherpeer-review

2018

Acceptability of opt-out consent in a hospital patient population

Boulos, D., Morand, E., Foo, M., Trivedi, J. D., Lai, R., Huntersmith, R., Zhang, K., Stark, C. B. & Le, S., 1 Jan 2018, In : Internal Medicine Journal. 48, 1, p. 84-87 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Analysis of serum interleukin (IL)-1β and IL-18 in systemic lupus erythematosus

Mende, R., Vincent, F. B., Kandane-Rathnayake, R., Koelmeyer, R., Lin, E., Chang, J., Hoi, A., Morand, E. F., Harris, J. & Lang, T., 7 Jun 2018, In : Frontiers in Immunology. 9, JUN, 10 p., 1250.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Open Access
File

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus

Vincent, F. B., Slavin, L., Hoi, A. Y., Kitching, A. R., Mackay, F., Harris, J., Kandane-Rathnayake, R. & Morand, E. F., 1 Jan 2018, In : Lupus Science and Medicine. 5, 1, 10 p., e000277.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Association between sledai-2k domains and organ damage accrual

Zhang, K., Boyd, S., Petitjean, F., Hoi, A., Koelmeyer, R., Morand, E. & Nim, H., 2018. 1 p.

Research output: Contribution to conferenceAbstractOtherpeer-review

Author Correction: Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo

Qin, C. X., Finlayson, S. B., Al-Sharea, A., Tate, M., De Blasio, M. J., Deo, M., Rosli, S., Prakoso, D., Thomas, C. J., Kiriazis, H., Gould, E., Yang, Y. H., Morand, E. F., Perretti, M., Murphy, A. J., Du, X. J., Gao, X. M. & Ritchie, R. H., 2 May 2018, In : Scientific Reports. 8, 1, p. 7185-7185 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

Discordance of patient and physician health status concerns in systemic lupus erythematosus

Golder, V., Ooi, JJY., Antony, A. S., Ko, T., Morton, S., Kandane-Rathnayake, R., Morand, EF. & Hoi, A. Y., 1 Mar 2018, In : Lupus. 27, 3, p. 501-506 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis

Odobasic, D., Jia, Y., Kao, W., Fan, H., Wei, X., Gu, R., Ngo, D., Richard Kitching, A., Holdsworth, S. R., Morand, E. F. & Yang, Y. H., 1 Aug 2018, In : International Immunopharmacology. 61, p. 140-149 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients

Lanata, C. M., Nititham, J., Taylor, K. E., Chung, S. A., Torgerson, D. G., Seldin, M. F., Pons-Estel, B. A., Tusié-Luna, T., Tsao, B. P., Morand, E. F., Alarcón-Riquelme, M. E. & Criswell, L. A., 1 Jun 2018, In : PLoS ONE. 13, 6, 15 p., e0199003.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Gilz-activin a as a novel signaling axis orchestrating mesenchymal stem cell and Th17 cell interplay

Luz-Crawford, P., Espinosa-Carrasco, G., Ipseiz, N., Contreras, R., Tejedor, G., Medina, D. A., Vega-Letter, A. M., Ngo, D., Morand, E. F., Pène, J., Hernandez, J., Jorgensen, C. & Djouad, F., 1 Jan 2018, In : Theranostics. 8, 3, p. 846-859 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

GILZ-dependent modulation of mTORC1 regulates spermatogonial maintenance

La, H. M., Chan, A-L., Legrand, J. M. D., Rossello, F. J., Gangemi, C. G., Papa, A., Cheng, Q., Morand, E. F. & Hobbs, R. M., 1 Sep 2018, In : Development. 145, 18, dev165324.

Research output: Contribution to journalArticleResearchpeer-review

Identification of a novel autoantibody against self-vimentin specific in secondary Sjögren's syndrome

Li, Y. H., Gao, Y. P., Dong, J., Shi, L. J., Sun, X. L., Li, R., Zhang, X. W., Liu, Y., Long, L., He, J., Zhong, Q. J., Morand, E., Yang, G. & Li, Z. G., 12 Feb 2018, In : Arthritis Research and Therapy. 20, 1, 8 p., 30.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus

Connelly, K. L., Kandane-Rathnayake, R., Huq, M., Hoi, A., Nikpour, M. & Morand, E. F., 1 Dec 2018, In : Scientific Reports. 8, 1, 9 p., 3268.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: Post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Morand, E. F., Trasieva, T., Berglind, A., Illei, G. G. & Tummala, R., 1 May 2018, In : Annals of the Rheumatic Diseases. 77, 5, p. 706-713 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation

Lang, T., Lee, J. P. W., Elgass, K., Pinar, A. A., Tate, M. D., Aitken, E. H., Fan, H., Creed, S. J., Deen, N. S., Traore, D. A. K., Mueller, I., Stanisic, D., Baiwog, F. S., Skene, C., Wilce, M. C. J., Mansell, A., Morand, E. F. & Harris, J., 1 Dec 2018, In : Nature Communications. 9, 1, 15 p., 2223.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Medical student psychological distress and academic performance

Dendle, C., Baulch, J., Pellicano, R., Hay, M., Lichtwark, I., Ayoub, S., Clarke, D. M., Morand, E. F., Kumar, A., Leech, M. & Horne, K., 22 Dec 2018, In : Medical Teacher. 40, 12, p. 1257-1263 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Routine Clinical Pathology Measurements Are Associated with Organ Damage Transition in SLE

Zhang, K., Boyd, S., Petitjean, F., Hoi, A., Koelmeyer, R., Morand, E. & Nim, H., 2018. 1 p.

Research output: Contribution to conferenceAbstractOtherpeer-review

Systemic lupus erythematosus: Stress and the onset of SLE

Morand, E. F., 1 Mar 2018, In : Nature Reviews Rheumatology. 14, 3, p. 127-128 2 p.

Research output: Contribution to journalShort SurveyOtherpeer-review

Time-Dependent Relationships between Biological Parameters and Disease Activity in Systemic Lupus Erythematosus

Connelly, K., Nim, H., Vincent, F., Petitjean, F., Hoi, A., Koelmeyer, R., Boyd, S. & Morand, E., 2018, In : Annals of the Rheumatic Diseases. 77, Suppl 2, p. 881-882 2 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus

Vincent, FB., Kandane-Rathnayake, R., Hoi, AY., Slavin, L., Godsell, JD., Kitching, AR., Harris, J., Nelson, C. L., Jenkins, A. J., Chrysostomou, A., Hibbs, ML., Kerr, PG., Rischmueller, M., Mackay, F. & Morand, EF., 1 Nov 2018, In : Lupus. 27, 13, p. 2029-2040 12 p.

Research output: Contribution to journalArticleResearchpeer-review

2017

A framework for remission in SLE: Consensus findings from a large international task force on definitions of remission in SLE (DORIS)

van Vollenhoven, R., Voskuyl, A., Bertsias, G., Aranow, C., Aringer, M., Arnaud, L., Askanase, A., Balážová, P., Bonfa, E., Bootsma, H., Boumpas, D., Bruce, I., Cervera, R., Clarke, A., Coney, C., Costedoat-Chalumeau, N., Czirják, L., Derksen, R., Doria, A., Dörner, T. & 38 others, Fischer-Betz, R., Fritsch-Stork, R., Gordon, C., Graninger, W., Györi, N., Houssiau, F., Isenberg, D., Jacobsen, S., Jayne, D., Kuhn, A., Guern, V. L., Lerstrøm, K., Levy, R., Machado-Ribeiro, F., Mariette, X., Missaykeh, J., Morand, E., Mosca, M., Inanc, M., Navarra, S., Neumann, I., Olesinska, M., Petri, M., Rahman, A., Rekvig, O. P., Rovensky, J., Shoenfeld, Y., Smolen, J., Tincani, A., Urowitz, M., van Leeuw, B., Vasconcelos, C., Voss, A., Werth, V. P., Zakharova, H., Zoma, A., Schneider, M. & Ward, M., 1 Mar 2017, In : Annals of the Rheumatic Diseases. 76, 3, p. 554-561

Research output: Contribution to journalArticleResearchpeer-review

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

Golder, V., Kandane-Rathnayake, R., Hoi, A. Y-B., Huq, M., Louthrenoo, W., An, Y., Li, Z. G., Luo, S. F., Sockalingam, S., Lau, C. S., Mok, M. Y., Lateef, A., Franklyn, K., Morton, S., Navarra, S. T. V., Zamora, L., Wu, Y. J., Hamijoyo, L., Chan, M., O'Neill, S. & 3 others, Goldblatt, F., Nikpour, M. & Morand, E. F., 20 Mar 2017, In : Arthritis Research and Therapy. 19, 1, 11 p., 62.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Cardiovascular risk profiles in a lupus cohort: What do different calculators tell us?

Boulos, D., Koelmeyer, R. L., Morand, E. F. & Hoi, A. Y., 1 Jul 2017, In : Lupus Science and Medicine. 4, 1, 5 p., 000212.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study

Golder, V., Huq, M., Franklyn, K., Calderone, A., Lateef, A., Lau, C. S., Lee, A. L. H., Navarra, S. T. V., Godfrey, T., Oon, S., Hoi, A. Y. B., Morand, E. & Nikpour, M., Jun 2017, In : Seminars in Arthritis and Rheumatism. 46, 6, p. 798-803 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice in Vivo

Qin, C. X., Finlayson, S. B., Ai-Sharea, A., Tate, M., De Blasio, M. J., Deo, M., Rosli, S., Prakoso, D., Thomas, C. J., Kiriazis, H., Gould, E., Yang, Y. H., Morand, E. F., Perretti, M., Murphy, A. J., Du, X. J., Gao, X. M. & Ritchie, R. H., 1 Dec 2017, In : Scientific Reports. 7, 1, 14 p., 16615.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

It hasn't gone away: the problem of glucocorticoid use in lupus remains

Apostolopoulos, D. & Morand, E. F., 1 Apr 2017, In : Rheumatology. 56, 1, p. i114-i122 9 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Quality of care for systemic lupus erythematosus: Mind the knowledge gap

Golder, V., Morand, E. F. & Hoi, A. Y., 1 Mar 2017, In : Journal of Rheumatology. 44, 3, p. 271-278 8 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

The Australian lupus registry and biobank: A timely initiative

O’Neill, S., Morand, E. F. & Hoi, A., 20 Mar 2017, In : Medical Journal of Australia. 206, 5, p. 194-195 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review